CARGO Therapeutics, Inc. Common Stock

NASDAQ (USD): CARGO Therapeutics, Inc. Common Stock (CRGX)

Last Price

3.39

Today's Change

-9.80 (74.29%)

Day's Change

3.00 - 3.49

Trading Volume

21,153,155

Overview

Market Cap

156 Million

Shares Outstanding

46 Million

Avg Volume

313,195

Avg Price (50 Days)

14.93

Avg Price (200 Days)

17.76

PE Ratio

-0.19

EPS

-17.59

Earnings Announcement

21-Mar-2025

Previous Close

13.19

Open

3.10

Day's Range

3.0 - 3.49

Year Range

3.0 - 33.92

Trading Volume

21,153,155

Price Change Highlight

1 Day Change

-74.30%

5 Day Change

-75.51%

1 Month Change

-75.36%

3 Month Change

-83.98%

6 Month Change

-79.94%

Ytd Change

-77.48%

1 Year Change

-85.20%

3 Year Change

-76.67%

5 Year Change

-76.67%

10 Year Change

-76.67%

Max Change

-76.67%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment